Abstract
Background: The pathological activation of innate immune system may contribute to the development of cardiometabolic diseases. The interferon regulatory factor (IRF) family members, which are the major transcription factors in innate immune signaling, are implicated in cardiometabolic diseases.
Objective: The aim of this review is to summary the current knowledge of the biological functions of IRFs in innate immune responses and immune cell development, and highlight our contemporary understanding of the functions and molecular mechanisms of IRFs in metabolic diseases, cardiovascular remodeling, and stroke.
Results: IRFs are the essential regulators of cardiometabolic diseases via immune-dependent and - independent manners.
Conclusion: IRFs signaling is the promising target to manage the initiation and progression of cardiometabolic disorders.
Keywords: Interferon regulatory factor signaling, metabolic diseases, cardiac remodeling, vascular injury, stroke, vascular remodeling.
Current Drug Targets
Title:Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges
Volume: 18 Issue: 15
Author(s): Yaxing Zhang, Xiao-Jing Zhang and Hongliang Li*
Affiliation:
- Department of Cardiology, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuhan 430060,China
Keywords: Interferon regulatory factor signaling, metabolic diseases, cardiac remodeling, vascular injury, stroke, vascular remodeling.
Abstract: Background: The pathological activation of innate immune system may contribute to the development of cardiometabolic diseases. The interferon regulatory factor (IRF) family members, which are the major transcription factors in innate immune signaling, are implicated in cardiometabolic diseases.
Objective: The aim of this review is to summary the current knowledge of the biological functions of IRFs in innate immune responses and immune cell development, and highlight our contemporary understanding of the functions and molecular mechanisms of IRFs in metabolic diseases, cardiovascular remodeling, and stroke.
Results: IRFs are the essential regulators of cardiometabolic diseases via immune-dependent and - independent manners.
Conclusion: IRFs signaling is the promising target to manage the initiation and progression of cardiometabolic disorders.
Export Options
About this article
Cite this article as:
Zhang Yaxing , Zhang Xiao-Jing and Li Hongliang *, Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges, Current Drug Targets 2017; 18 (15) . https://dx.doi.org/10.2174/1389450116666150804110412
DOI https://dx.doi.org/10.2174/1389450116666150804110412 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cytokines as Targets in Chronic Obstructive Pulmonary Disease
Current Drug Targets Genome Wide Analysis of Chlamydia pneumoniae for Candidate Vaccine Development
Current Computer-Aided Drug Design Inhibition of microRNA-155 Alleviates Neurological Dysfunction Following Transient Global Ischemia and Contribution of Neuroinflammation and Oxidative Stress in the Hippocampus
Current Pharmaceutical Design Molecular Docking and ADME Studies of Natural Compounds of Agarwood Oil for Topical Anti-Inflammatory Activity
Current Computer-Aided Drug Design Exploring Interaction of TNF and Orthopoxviral CrmB Protein by Surface Plasmon Resonance and Free Energy Calculation
Protein & Peptide Letters Editorial [Hot Topic: The Kinetics and Profiles of Inflammatory Cells During Inflammatory and Allergic Responses (Guest Editor: Tsuyoshi Kasama)]
Current Drug Targets - Inflammation & Allergy Ambient Pollution and COPD
Current Respiratory Medicine Reviews Role of Natural Killer Cell Activity in the Pathogenesis of Endometriosis
Current Medicinal Chemistry Can Anthropometric and Body Composition Measurements During Pregnancy be Used to Predict Preeclampsia Risk?
Current Women`s Health Reviews A Critical Approach of the Current Treatment of Anxiety Disorders
Current Psychopharmacology Functional Regulation of Hepatic Cytochrome P450 Enzymes by Physicochemical Properties of Phospholipids in Biological Membranes
Current Protein & Peptide Science Amyloid A in Serum and Ascitic Fluid as a Novel Diagnostic Marker of Spontaneous Bacterial Peritonitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Coagulation and Cancer Therapy: The Potential of Natural Compounds
Current Genomics Predictive Factors for Disability as Evaluated by the Health Assessment Questionnaire in Rheumatoid Arthritis: A Literature Review
Inflammation & Allergy - Drug Targets (Discontinued) Computational Drug Repositioning for Cancer Therapeutics
Current Topics in Medicinal Chemistry Preventive Effects of Mallotus japonicus Cortex Extracts on Dextran Sulfate Sodium-Induced Ulcerative Colitis in C57 BL/6J Mice
The Natural Products Journal Targeting Mechanism of a Novel Liver-targeting Interferon IFN-CSP Involves Liver Heparan Sulfate Proteoglycan
Current Drug Delivery Antiviral Agents in the Prevention and Treatment of Virus-Induced Diabetes
Anti-Infective Agents in Medicinal Chemistry Promising Anti-Fibrotic Approaches for Future Treatment of Systemic Sclerosis
Current Rheumatology Reviews Enantioselective Synthesis of 2,3-Disubstituted Piperidines
Letters in Organic Chemistry